Cantor Fitzgerald Comments on TNGX FY2026 Earnings
Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for Tango Therapeutics in a report issued on Monday, June 9th. Cantor Fitzgerald analyst E. Schmidt expects that the company will post earnings per share of ($1.58) for the year. The consensus estimate for Tango Therapeutics’ current […]
Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for Tango Therapeutics in a report issued on Monday, June 9th. Cantor Fitzgerald analyst E. Schmidt expects that the company will post earnings per share of ($1.58) for the year. The consensus estimate for Tango Therapeutics’ current […]
